Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Toyota Reports 2.3% Sales Drop as China Weakness Deepens - 2Moon memorial: Artemis 2 astronauts name lunar 'bright spot' after mission commander's late wife
- 3Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
- 4The most effective method to Boost Benefits in Gold Speculation: Master Techniques and Tips
- 5James Webb Space Telescope discovers a lemon-shaped exoplanet unlike anything seen before: 'What the heck is this?'
- Scientists solve the mystery of the prehistoric 'Burtele Foot'
- Upgrading the Healthy benefit of Your Local Vegetables
- Find the Keys to Fruitful Venture The board: Conveying Results on Time
- 10 Distinct Kinds of Chinese Neighborhood Specialty Hot Pot
- Brazil's agricultural research agency gets cannabis research greenlight
- Pfizer in $41.5 million settlement with Texas over ADHD drug for children
- Picking the Right Home Machines: A Commonsense Aide
- Navy-Marine Corps Relief Society provides emergency grants to families displaced by Iran war
- Mountain Trekking on a Tight spending plan: Tracking down the Right Bicycle
